Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases July 13, 2026 Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease July 06, 2026 Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit May 12, 2026 Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview (May 12, 2026) 4.8 MB OpRegen® 3 Year Clinical Data Update (Retinal Innovation Summit 2026) 2.1 MB Roche Pharma Day 2025 Presentation 8.1 MB COR1 Cell Therapy Program for Corneal Endothelial Disease Developmental Updates Call Jul 13, 2026 at 4:30 PM EDT Click here for webcast VIEW EVENTS & PRESENTATIONS
July 06, 2026 Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
May 12, 2026 Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
COR1 Cell Therapy Program for Corneal Endothelial Disease Developmental Updates Call Jul 13, 2026 at 4:30 PM EDT Click here for webcast
